# A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Study · id `cardio:ct-nct05036135` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05036135](<https://clinicaltrials.gov/study/NCT05036135>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05036135

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 202 participants.

## Technical summary

Registry record NCT05036135. Randomized; quadruple masking; primary purpose treatment. Start 2021-12-02 (actual); primary completion 2024-08-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 202 participants (enrolled count; ClinicalTrials.gov record NCT05036135, source copy `cardio:ctgov-nct05036135-2024-08-23`, retrieved 2026-10-31)
- Started: 2021-12-02 (actual) (ClinicalTrials.gov record NCT05036135, source copy `cardio:ctgov-nct05036135-2024-08-23`, retrieved 2026-10-31)
- Primary completion: 2024-08-09 (actual) (ClinicalTrials.gov record NCT05036135, source copy `cardio:ctgov-nct05036135-2024-08-23`, retrieved 2026-10-31)
- Completion: 2024-08-09 (actual) (ClinicalTrials.gov record NCT05036135, source copy `cardio:ctgov-nct05036135-2024-08-23`, retrieved 2026-10-31)
- Countries: United States; Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Czechia; France; Germany; Greece; Israel; Italy; Latvia; Mexico; Netherlands; Poland; Portugal; Puerto Rico; Singapore; South Africa; Spain; Sweden; United Kingdom (ClinicalTrials.gov record NCT05036135, source copy `cardio:ctgov-nct05036135-2024-08-23`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05036135-2024-08-23`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)
- Acronym: IMPAHCT
- Condition: Pulmonary Arterial Hypertension
- Intervention (Drug): AV-101
- Intervention (Drug): Placebo
- Lead sponsor: Aerovate Therapeutics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary arterial hypertension (`cardio:pulmonary-arterial-hypertension`)
- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension (`cardio:pubmed-41738079`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 59b0cb483390bdd3c91531ccdefac888ddb19ab41e593b9188dc62b8774cccb3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
